Tiny Sernova Corp On Cutting Edge Of Cell Delivery Systems

Jun. 03, 2015 11:42 AM ETMBOT, STML, SCAL, SGNI, STSBD, CLDX, IPIX, CEL, ICEL, CBMG, CLRB, CMXC
Retirefund profile picture
Retirefund's Blog
178 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Special Situations, Deep Value, Long/Short Equity, Contrarian

Contributor Since 2009

Long a buy and hold investor, I now believe that buy and hold has to be re-evaluated in a world of ever increasing, instant information and huge gyrations in markets all over the world. A value investor at heart, I anchor my portfolio with conservative funds and blue chip dividend stocks, but have enjoyed great returns by utilizing a portion of my portfolio on microcaps, cleantech and new technology stocks. That change in sentiment resulted in a 471% return over two years.

Sernova Corps new cell poach delivery system can deliver Medicine and therapies directly to the cells of patients- Sernova now has 55 patents or patents pending for it's unique, personal approach to curing and/or reversing many forms of illness.

Sernova is forging the "picks and shovels" so to speak of the new medical frontier. Many companies currently working on stem cell research, et al, will benefit from this cutting edge delivery system.

Sernova Corp is currently a penny stock and trades on the Toronto TSX Venture Exchange under .20 cents, but we don't expect that will last very long. Symbol SVA-->See Retirefunds.com

See our next entry (below) on this innovative new approach.

Disclosure: The author is long SVA.T.

Additional disclosure: Long SVA-T

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.